BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amirouche A, Jahnke VE, Lunde JA, Koulmann N, Freyssenet DG, Jasmin BJ. Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations. American Journal of Physiology-Cell Physiology 2017;312:C209-21. [DOI: 10.1152/ajpcell.00185.2016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Park SS, Kwon ES, Kwon KS. Molecular mechanisms and therapeutic interventions in sarcopenia. Osteoporos Sarcopenia 2017;3:117-22. [PMID: 30775515 DOI: 10.1016/j.afos.2017.08.098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
2 Mihály D, Papp G, Mervai Z, Reszegi A, Tátrai P, Szalóki G, Sápi J, Sápi Z. The oncomir face of microRNA-206: A permanent miR-206 transfection study. Exp Biol Med (Maywood) 2018;243:1014-23. [PMID: 30111166 DOI: 10.1177/1535370218795406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mousa NO, Abdellatif A, Fahmy N, Zada S, El-Fawal H, Osman A. Circulating MicroRNAs in Duchenne Muscular Dystrophy. Clin Neurol Neurosurg 2020;189:105634. [PMID: 31838454 DOI: 10.1016/j.clineuro.2019.105634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Barp A, Ferrero A, Casagrande S, Morini R, Zuccarino R. Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New. Biomolecules 2021;11:1246. [PMID: 34439911 DOI: 10.3390/biom11081246] [Reference Citation Analysis]
5 Pietraszek-gremplewicz K, Kozakowska M, Bronisz-budzynska I, Ciesla M, Mucha O, Podkalicka P, Madej M, Glowniak U, Szade K, Stępniewski J, Jez M, Andrysiak K, Bukowska-strakova K, Kaminska A, Kostera-pruszczyk A, Józkowicz A, Loboda A, Dulak J. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Antioxidants & Redox Signaling 2018;29:128-48. [DOI: 10.1089/ars.2017.7435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
6 Guiraud S, Roblin D, Kay DE. The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy. Expert Opinion on Orphan Drugs 2018;6:179-92. [DOI: 10.1080/21678707.2018.1438261] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
7 Guiraud S, Edwards B, Squire SE, Moir L, Berg A, Babbs A, Ramadan N, Wood MJ, Davies KE. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD. Hum Mol Genet 2019;28:307-19. [PMID: 30304405 DOI: 10.1093/hmg/ddy353] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
8 Li Y, Shi H, Chen R, Zhou S, Lei S, She Y. Role of miRNAs and lncRNAs in dexamethasone-induced myotube atrophy in vitro. Exp Ther Med 2021;21:146. [PMID: 33456513 DOI: 10.3892/etm.2020.9577] [Reference Citation Analysis]
9 Florian A, Patrascu A, Tremmel R, Rösch S, Sechtem U, Schwab M, Schaeffeler E, Yilmaz A. Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach. Front Physiol 2018;9:1770. [PMID: 30622476 DOI: 10.3389/fphys.2018.01770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhao H, Chen J, Chen J, Kong X, Zhu H, Zhang Y, Dong H, Wang J, Ren Q, Wang Q, Chen S, Deng Z, Chen Z, Cui Q, Zheng J, Lu J, Wang S, Tan J. miR-192/215-5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study. J Cell Physiol 2019;234:21060-75. [PMID: 31020657 DOI: 10.1002/jcp.28709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
11 Brusa R, Magri F, Bresolin N, Comi GP, Corti S. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives. Cell Mol Life Sci 2020;77:4299-313. [PMID: 32350552 DOI: 10.1007/s00018-020-03537-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Izzotti A, Longobardi M, La Maestra S, Micale RT, Pulliero A, Camoirano A, Geretto M, D'Agostini F, Balansky R, Miller MS, Steele VE, De Flora S. Release of MicroRNAs into Body Fluids from Ten Organs of Mice Exposed to Cigarette Smoke. Theranostics 2018;8:2147-60. [PMID: 29721069 DOI: 10.7150/thno.22726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
13 Bronisz-Budzyńska I, Chwalenia K, Mucha O, Podkalicka P, Karolina-Bukowska-Strakova, Józkowicz A, Łoboda A, Kozakowska M, Dulak J. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skelet Muscle 2019;9:22. [PMID: 31412923 DOI: 10.1186/s13395-019-0207-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
14 Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, Hurtig HI, Chen-Plotkin A, Wolk DA, McCluskey LF, Elman LB, Trojanowski JQ, Umansky SR. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther 2017;9:89. [PMID: 29121998 DOI: 10.1186/s13195-017-0316-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 13.2] [Reference Citation Analysis]